Patents by Inventor Nobuhiro Nishiyama

Nobuhiro Nishiyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12239619
    Abstract: The object is to provide a method for inducing pili formation in bacterium of genus Bifidobacterium and a method for promoting intestinal colonization of the bacterium. 3-Phenylpropionic acid and/or 3-(4-hydroxyphenyl)propionic acid are an active ingredient of a composition for inducing the pili formation in the bacterium of genus Bifidobacterium and a composition for promoting the intestinal colonization of the bacterium.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: March 4, 2025
    Assignees: Morinaga Milk Industry Co., Ltd., National University Corporation Kobe University, The Kitasato Institute
    Inventors: Kanetada Shimizu, Ro Osawa, Keita Nishiyama, Nobuhiko Okada, Nobuhiro Koyama, Takao Mukai, Hiroshi Tomoda
  • Patent number: 12239713
    Abstract: The invention provides a bio-related substance bonded to a high-molecular-weight polyethylene glycol derivative that does not cause vacuolation of cells. The bio-related substance bonded to a degradable polyethylene glycol derivative is represented by the formula (A): wherein m is 1-7, n1 and n2 are each independently 45-682, p is 1-4, R is an alkyl group having 1-4 carbon atoms, Z is an oligopeptide with 2-8 residues composed of neutral amino acids excluding cysteine, Q is a residue of a compound having 2-5 active hydrogens, D is the bio-related substance, L1, L2, L3, L4 and L5 are each independently a single bond or a divalent spacer, and y is 1-40.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 4, 2025
    Assignees: NOF CORPORATION, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Hiroki Yoshioka, Masaki Kamiya, Yuji Yamamoto, Midori Hirai, Akiko Sasaki, Nobuhiro Nishiyama, Makoto Matsui, Hiroyasu Takemoto, Kazuki Miyauchi, Takahiro Nomoto, Keishiro Tomoda
  • Patent number: 12187846
    Abstract: The invention provides a high-molecular-weight polyethylene glycol derivative that does not cause vacuolation of cells. The degradable polyethylene glycol derivative is represented by the following formula (1): wherein m is 1-7, n1 and n2 are each independently 45-682, p is 1-4, R is an alkyl group having 1-4 carbon atoms, Z is an oligopeptide with 2-8 residues composed of neutral amino acids excluding cysteine, Q is a residue of a compound having 2-5 active hydrogens, X is a functional group capable of reacting with a bio-related substance, and L1, L2, L3, L4 and L5 are each independently a single bond or a divalent spacer.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: January 7, 2025
    Assignees: NOF Corporation, Tokyo Institute of Technology
    Inventors: Hiroki Yoshioka, Masaki Kamiya, Yuji Yamamoto, Midori Hirai, Akiko Sasaki, Nobuhiro Nishiyama, Makoto Matsui, Hiroyasu Takemoto, Kazuki Miyauchi, Takahiro Nomoto, Keishiro Tomoda
  • Publication number: 20240374733
    Abstract: The present invention provides a pH-responsive lipid derivative represented by a structure represented by the following formula (i): (in the above-mentioned formula, each symbol is as described in the specification), and a pH-responsive transport carrier which is useful as a transport carrier for safely and efficiently performing delivery of low-molecular-weight drugs and the like to tumor tissues.
    Type: Application
    Filed: July 6, 2022
    Publication date: November 14, 2024
    Applicants: NOF Corporation, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Koichi OGI, Junya MICHINISHI, Tomoyuki OHTAKE, Nobuhiro NISHIYAMA, Hiroyasu TAKEMOTO, Yutaka MIURA, Takahiro NOMOTO, Makoto MATSUI, Yi-Jung SUNG, Masahiro TOYODA, Aria GHASEMIZADEH
  • Publication number: 20240301137
    Abstract: The present invention provides a highly pure pH-responsive polymer represented by the following formula (I), a production method thereof, and the like: (in the formula (I), each symbol is as described in the specification).
    Type: Application
    Filed: July 6, 2022
    Publication date: September 12, 2024
    Applicants: NOF CORPORATION, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Koichi OGI, Junya MICHINISHI, Tomoyuki OHTAKE, Muneaki IIZUKA, Nobuhiro NISHIYAMA, Hiroyasu TAKEMOTO, Yutaka MIURA, Takahiro NOMOTO, Makoto MATSUI, Yi-Jung SUNG, Masahiro TOYODA, Aria GHASEMIZADEH
  • Patent number: 11890347
    Abstract: A pH-responsive polymer formed of a biocompatible polymer to which a group which is electrically neutral under pH environments of more than 7 and which changes to be cationic at pH 7 or less is bonded.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: February 6, 2024
    Assignee: Tokyo Institute of Technology
    Inventors: Nobuhiro Nishiyama, Hiroyasu Takemoto, Abdul-Hackam Ranneh, Keishiro Tomoda, Takahiro Nomoto, Makoto Matsui
  • Patent number: 11707530
    Abstract: The present invention pertains to a ligand that contains a plurality of groups represented by formula (1) and is capable of multivalently binding to a glutamine transporter expressed in excess in a cancer cell compared to a normal cell.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: July 25, 2023
    Assignees: TOKYO INSTITUTE OF TECHNOLOGY, OSAKA UNIVERSITY
    Inventors: Nobuhiro Nishiyama, Hiroyasu Takemoto, Takahiro Nomoto, Keishiro Tomoda, Makoto Matsui, Naoki Yamada, Yuto Honda, Hideshi Ishii, Masaki Mori, Masamitsu Konno
  • Patent number: 11555082
    Abstract: The present invention pertains to: a p-boronophenylalanine derivative that comprises a polymer to which a group represented by formula (I) is linked directly or via a linker; a composition containing same; and a kit for producing said derivative and composition.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: January 17, 2023
    Assignee: TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Nobuhiro Nishiyama, Takahiro Nomoto, Yukiya Inoue, Ying Yao, Kaito Kanamori, Hiroyasu Takemoto, Makoto Matsui, Keishiro Tomoda
  • Publication number: 20220387609
    Abstract: A bio-related substance bonded to a branched and degradable polyethylene glycol derivative that is degraded in the cells represented by the following formula (A): wherein each symbol is as defined in the present specification, is provided by the present invention.
    Type: Application
    Filed: March 26, 2020
    Publication date: December 8, 2022
    Applicants: NOF CORPORATION, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Hiroki YOSHIOKA, Kazuki OSAKAMA, Mika HAMURA, Takanori INABA, Nobuhiro NISHIYAMA, Makoto MATSUI, Hiroyasu TAKEMOTO, Takahiro NOMOTO, Xiaohang SUN
  • Publication number: 20220380533
    Abstract: A multi-arm, degradable polyethylene glycol derivative with a high molecular weight that does not cause vacuolation of cells is provided. A degradable polyethylene glycol derivative represented by the following formula (1): wherein n1 and n2 are each independently 45-950, W1 and W2 are each independently an oligopeptide of 2-47 residues, a1 and a2 are each independently 1-8, Q is a hydrocarbon chain having 2-12 carbon atoms and optionally containing an oxygen atom and/or a nitrogen atom, X1 and X2 are each independently a functional group capable of reacting with a bio-related substance, and L1, L2, L3, L4, L5 and L6 are each independently a divalent spacer.
    Type: Application
    Filed: September 25, 2020
    Publication date: December 1, 2022
    Inventors: Hiroki Yoshioka, Ken Hamura, Kazuki Osakama, Nobuhiro Nishiyama
  • Publication number: 20220339290
    Abstract: A branched degradable polyethylene glycol derivative with a high molecular weight that does not cause vacuolation of cells is provided. A branched degradable polyethylene glycol derivative represented by the following formula (1), containing, in a molecule, an oligopeptide that is degraded in the cells: wherein k1 and k2 are each independently 1-12, j1 and j2 are each independently 45-950, R is a hydrogen atom, a substituted or unsubstituted alkyl group having 1-12 carbon atoms, a substituted aryl group, an aralkyl group or a heteroalkyl group, Z is an oligopeptide that is degraded by enzyme in the cells, X is a functional group capable of reacting with a bio-related substance, and L1 and L2 are each independently a single bond or a divalent spacer.
    Type: Application
    Filed: September 25, 2020
    Publication date: October 27, 2022
    Inventors: Ken Hamura, Hiroki Yoshioka, Kazuki Osakama, Nobuhiro Nishiyama
  • Publication number: 20220265836
    Abstract: A complex is provided comprising a conjugate in which a polymer having a boronic acid group and a compound having a diol structure are bonded, and a substance that is complexed with the conjugate.
    Type: Application
    Filed: May 29, 2020
    Publication date: August 25, 2022
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION
    Inventors: Nobuhiro Nishiyama, Yuto Honda, Takahiro Nomoto, Hiroyasu Takemoto, Makoto Matsui, Hiroaki Kinoh, Kazunori Kataoka, Xueying Liu, Anjaneyulu Dirisala
  • Publication number: 20220211646
    Abstract: A conjugate is provided in which a deferoxamine-type compound, which is at least one compound selected from the group consisting of deferoxamine or an ion or salt thereof, and a derivative thereof, and a biocompatible polymer are conjugated, where the biocompatible polymer contains a first biocompatible polymer chain and a second biocompatible polymer chain that is different from the first biocompatible polymer chain.
    Type: Application
    Filed: April 23, 2020
    Publication date: July 7, 2022
    Inventors: Nobuhiro NISHIYAMA, Takahiro NOMOTO, Kana KOHMOTO, Hiroyasu TAKEMOTO, Makoto MATSUI
  • Patent number: 11376266
    Abstract: The present invention is directed to provide antitumor agent including water-soluble sulfasalazine as an active ingredient. Antitumor agents were obtained with, as the water-soluble sulfasalazine, a PEG-modified sulfasalazine represented by the following formula: wherein an average value of n is 4 or larger and 1136 or smaller.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: July 5, 2022
    Assignees: Keio University, Tokyo Institute of Technology
    Inventors: Hideyuki Saya, Osamu Nagano, Kenji Tsuchihashi, Kentaro Suina, Nobuhiro Nishiyama, Hiroyasu Takemoto, Takahiro Nomoto, Makoto Matsui, Keishiro Tomoda, Naoki Yamada, Tsukasa Nishimori
  • Publication number: 20220153992
    Abstract: An intracellularly degraded branched and degradable polyethylene glycol derivative represented by the following formula (1): wherein each symbol is as defined in the present specification, that is used for modifying bio-related substances is provided by the present invention.
    Type: Application
    Filed: March 26, 2020
    Publication date: May 19, 2022
    Applicants: NOF CORPORATION, TOKYO INSTITUTE OF TECHNOLOGY
    Inventors: Hiroki YOSHIOKA, Kazuki OSAKAMA, Mika HAMURA, Takanori INABA, Nobuhiro NISHIYAMA, Makoto MATSUI, Hiroyasu TAKEMOTO, Takahiro NOMOTO, Xiaohang SUN
  • Publication number: 20210308271
    Abstract: The present invention pertains to a ligand that contains a plurality of groups represented by formula (1) and is capable of multivalently binding to a glutamine transporter expressed in excess in a cancer cell compared to a normal cell.
    Type: Application
    Filed: August 17, 2017
    Publication date: October 7, 2021
    Applicants: TOKYO INSTITUTE OF TECHNOLOGY, OSAKA UNIVERISTY
    Inventors: Nobuhiro Nishiyama, Hiroyasu Takemoto, Takahiro Nomoto, Keishiro Tomoda, Makoto Matsui, Naoki Yamada, Yuto Honda, Hideshi Ishii, Masaki Mori, Masamitsu Konno
  • Patent number: 11020418
    Abstract: A unit structure-type pharmaceutical composition includes a single nucleic acid, such as an antisense nucleic acid, electrostatically bound to a single block copolymer having a cationic polyamino acid segment and a hydrophilic polymer chain segment. The negative charges of the nucleic acid are counterbalanced, at least substantially, by the positive charges of the cationic polyamino acid segment such that the pharmaceutical composition is electrically neutral or nearly electrically neutral. Further, the nucleic acid is covered with the hydrophilic polymer chain segment. The block copolymer thereby improves the blood retention capability of the nucleic acids.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: June 1, 2021
    Assignees: NANOCARRIER CO., LTD., THE UNIVERSITY OF TOKYO
    Inventors: Kazunori Kataoka, Kanjiro Miyata, Nobuhiro Nishiyama, Kensuke Osada, Sumiyo Watanabe, Shigeto Fukushima, Hiroyuki Chaya, Hiroyasu Takemoto, Yasuki Kato
  • Publication number: 20210147624
    Abstract: The invention provides a high-molecular-weight polyethylene glycol derivative that does not cause vacuolation of cells. The degradable polyethylene glycol derivative is represented by the following formula (1): wherein m is 1-7, n1 and n2 are each independently 45-682, p is 1-4, R is an alkyl group having 1-4 carbon atoms, Z is an oligopeptide with 2-8 residues composed of neutral amino acids excluding cysteine, Q is a residue of a compound having 2-5 active hydrogens, X is a functional group capable of reacting with a bio-related substance, and L1, L2, L3, L4 and L5 are each independently a single bond or a divalent spacer.
    Type: Application
    Filed: March 29, 2019
    Publication date: May 20, 2021
    Applicants: NOF Corporation, Tokyo Institute of Technology
    Inventors: Hiroki YOSHIOKA, Masaki KAMIYA, Yuji YAMAMOTO, Midori HIRAI, Akiko SASAKI, Nobuhiro NISHIYAMA, Makoto MATSUI, Hiroyasu TAKEMOTO, Kazuki MIYAUCHI, Takahiro NOMOTO, Keishiro TOMODA
  • Publication number: 20210046190
    Abstract: An object to be achieved by the present invention is to provide a technique for enhancing the anticancer effect of ubenimex; in particular, enhancing its anticancer effect on solid cancer. This object can be achieved by a compound containing a chain structure in which a plurality of ubenimex molecules is linked to a chain polymer.
    Type: Application
    Filed: January 30, 2019
    Publication date: February 18, 2021
    Inventors: Masaki MORI, Hideshi ISHII, Masamitsu KONNO, Hidetoshi EGUCHI, Naotsugu HARAGUCHI, Reishi TOSHIYAMA, Nobuhiro NISHIYAMA, Hiroyasu TAKEMOTO
  • Publication number: 20210040244
    Abstract: The present invention pertains to: a p-boronophenylalanine derivative that comprises a polymer to which a group represented by formula (I) is linked directly or via a linker; a composition containing same; and a kit for producing said derivative and composition.
    Type: Application
    Filed: February 19, 2019
    Publication date: February 11, 2021
    Inventors: Nobuhiro NISHIYAMA, Takahiro NOMOTO, Yukiya INOUE, Ying YAO, Kaito KANAMORI, Hiroyasu TAKEMOTO, Makoto MATSUI, Keishiro TOMODA